Sub Banner Image

Keensight Buys Majority Stake in Isto in $1 Billion Deal

Markets

Swetha Gopinath

·

September 17, 2025

·

Bloomberg

European private equity firm Keensight Capital agreed to acquire a majority stake in orthobiologic product maker Isto Biologics from Thompson Street Capital Partners, as the pickup in mid-sized deals continues.

More from

Bloomberg

More

Markets

Articles

Trending News

Enjoy premium content in your inbox.

You're in! Check your email to learn more.
Oops! Something went wrong while submitting the form.